CD8A and neoplasm: Time course analysis revealed a marked early increase of TAS CD8+ T cells (~ 10%) in intrahepatic tumor-infiltrating lymphocytes (TIL) one week after tumor injection compared to minimal levels of TAS CD8+ T cells in other tested tissues.